Assessing organ at risk position variation and its impact on delivered dose in kidney SABR [0.03%]
评估风险器官位置变化及其对肾脏SABR递送剂量的影响
Mathieu Gaudreault,Shankar Siva,Tomas Kron et al.
Mathieu Gaudreault et al.
Background: Delivered organs at risk (OARs) dose may vary from planned dose due to interfraction and intrafraction motion during kidney SABR treatment. Cases of bowel stricture requiring surgery post SABR treatment were r...
Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer [0.03%]
影像引导自适应放疗中瘤区扩大处方的亚临床运动校正对直肠癌患者PTV的影响研究
Chavelli M Kensen,Tomas M Janssen,Anja Betgen et al.
Chavelli M Kensen et al.
Purpose: To determine PTV margins for intrafraction motion in MRI-guided online adaptive radiotherapy for rectal cancer and the potential benefit of performing a 2nd adaptation prior to irradiation. ...
Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center [0.03%]
武汉协和医院肿瘤中心局部晚期直肠癌新辅助治疗现状
Meng-Lan Zhai,Fang-Yuan Zhang,Jin-Ru Yang et al.
Meng-Lan Zhai et al.
Background: To analyze and explore the evolution and short-term efficacy of neoadjuvant therapy for patients with mid and low LARC in Wuhan Union Hospital Cancer Center. ...
Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review [0.03%]
立体定向放疗在提高局部晚期胰腺导管腺癌患者生活质量中的作用：系统综述
Marlies Vornhülz,Sofia Anton,Balint Eross et al.
Marlies Vornhülz et al.
Introduction: Up to 30% of pancreatic cancer patients initially present locally advanced (LAPC). Stereotactic body radiation therapy (SBRT) may be an additional palliative treatment option when curative resection is no lo...
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy [0.03%]
p16阳性和p16阴性接受放射治疗的口腔鳞癌患者的原发肿瘤体积与预后关系分析
Gabriel Adrian,Henrik Carlsson,Elisabeth Kjellén et al.
Gabriel Adrian et al.
Background: The prescribed radiation dose to patients with oropharyngeal squamous cell carcinoma (OPSCC) is standardized, even if the prognosis for individual patients may differ. Easy-at-hand pre-treatment risk stratific...
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study [0.03%]
放疗联合抗PD-1治疗与导管动脉化疗栓塞术联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：一项真实世界研究
Jian-Xu Li,Wen-Xiang Deng,Shi-Ting Huang et al.
Jian-Xu Li et al.
Background: The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepato...
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial [0.03%]
紫杉醇和顺铂联合同期局部照射在局晚期食管鳞癌根治性同步放化疗中的应用：II期临床试验
Hui Li,Ying Fang,Dayong Gu et al.
Hui Li et al.
Purpose: This trial aims to explore the efficacy and safety of involved-field irradiation (IFI) combined with paclitaxel plus cisplatin as concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcino...
Initial clinical experience of surface guided stereotactic radiation therapy with open-face mask immobilization for improving setup accuracy: a retrospective study [0.03%]
开放式面膜固定体表引导立体定向放射治疗改善摆位误差的初步临床研究（回顾性）
Shun Zhou,Junyu Li,Xianggao Zhu et al.
Shun Zhou et al.
Purpose: To propose a specific surface guided stereotactic radiotherapy (SRT) treatment procedure with open-face mask immobilization and evaluate the initial clinical experience in improving setup accuracy. ...
High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region [0.03%]
高剂量立体定向放射治疗在头颈部鳞状细胞癌治疗中的应用
Paweł Polanowski,Agnieszka Pietruszka,Dorota Księżniak-Baran et al.
Paweł Polanowski et al.
Background: Surgical resection with adjuvant concurrent radiochemotherapy is the standard of care for stage III-IV oral cavity cancer. In some cases, the dynamic course of the disease is out of the prepared schedule of tr...
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3) [0.03%]
磁共振引导自适应立体定向体放射治疗超中央位置的肺肿瘤：MAGELLAN试验（ARO 2021-3）
Sebastian Regnery,Jonas Ristau,Fabian Weykamp et al.
Sebastian Regnery et al.
Background: Stereotactic Body Radiotherapy (SBRT) is a standard treatment for inoperable primary and secondary lung tumors. In case of ultracentral tumor location, defined as tumor contact with vulnerable mediastinal stru...